Cavan John T 4
4 · Hepion Pharmaceuticals, Inc. · Filed Feb 18, 2021
Insider Transaction Report
Form 4
Cavan John T
Chief Financial Officer
Transactions
- Purchase
Common Stock
2021-02-18$2.00/sh+10,000$20,000→ 14,800 total
4 · Hepion Pharmaceuticals, Inc. · Filed Feb 18, 2021
Common Stock